News
-
Novo Nordisk-partnered drug shows 19.7% weight loss in Phase II trial
UBT251 is being jointly developed by United Bio-Technology and Novo Nordisk under a March 2025 agree...Read more -
New Hope Against Multidrug-Resistant Pseudomonas aeruginosa:Scientific Breakthrough of Murepavadin.
In the face of increasingly severe multidrug-resistant bacterial infections, the development progres...Read more -
ARA-290: A Next-Generation Peptide for Accelerated Skin Healing
ARA-290: A Next-Generation Peptide for Accelerated Skin HealingWound healing is a complex process, a...Read more -
FDA Approves the First Oral GLP-1 Weight Management Therapy: Drug Delivery Technologies Enter a New Era
The U.S. Food and Drug Administration (FDA) approved the world’s first oral glucagon-like peptide-1...Read more -
Palmitoyl Tripeptide-1
Palmitoyl Tripeptide-1: Boost Your Skin’s Elasticity!Say goodbye to those annoying wrinkles tha...Read more -
Solid-phase synthesis method of Melanotan I
Melanotan I, also known as Afamelanotide, is a linear polypeptide composed of 13 amino acids that is...Read more -
Synthetic Pathway of Polypeptides and Proteins in Amino Acid Dehydration Condensation
Amino acids form polypeptide proteins through condensation reactions, following certain rules. This...Read more -
Not just reducing blood sugar and weight! Somalutide ushers in a new era of multi disease treatment, clinical trials provide strong evidence
When it comes to semaglutide, many people are familiar with its hypoglycemic and weight reducing eff...Read more -
Sanya Conference Record: GoTop Biotechnology delves deeper into the peptide field and discusses technological breakthroughs and industrial landing with industry university research partners
The 11th National Peptide Drug R&D and Scale Production Frontier Technology Academic Exchange Confer...Read more -
Go Top Biotech Makes Its Debut at CPHI Frankfurt 2025, Connecting European Business Opportunities Through End-to-End Supply Chain Services
From October 28 to 30, 2025, the 2025 World Pharmaceutical Ingredients Europe Exhibition (CPHI Frank...Read more -
Future Potential Oral GLP-1 Weight Loss Drug - Amycritin
Novo Nordisk's latest Phase II clinical data show that the single molecule GLP-1+amylin dual agonist...Read more -
New Breakthrough in Vitiligo Treatment! KPV Tripeptide Biomimetic Synergistic Strategy Offers New Hope for Pigmentation Restoration
Vitiligo is a globally prevalent acquired skin disorder characterized by localized or generalized de...Read more